METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression
Peng, Wei, Fu, Jia, Zhou, Lijun, Duan, Huaxin
Published in Cancer medicine (Malden, MA) (01.07.2024)
Published in Cancer medicine (Malden, MA) (01.07.2024)
Get full text
Journal Article
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
Xie, Yijun, Xiao, Di, Li, Duo, Peng, Mei, Peng, Wei, Duan, Huaxin, Yang, Xiaoping
Published in Frontiers in oncology (02.08.2024)
Published in Frontiers in oncology (02.08.2024)
Get full text
Journal Article
Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)
Wu, Lin, Deng, Chao, Zhang, Hui, Weng, Jie, Wu, Youhua, Zeng, Shan, Tang, Tiegang, Cao, Peiguo, Qiu, Bo, Zhang, Li, Duan, Huaxin, Zhang, Bing, Zhang, Dong, Zhang, Taotao, Hu, Chunhong
Published in Frontiers in oncology (14.12.2021)
Published in Frontiers in oncology (14.12.2021)
Get full text
Journal Article
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy
Cai, Qingqing, Chen, Kailin, Chen, Jie, Wu, Shaoxu, Geng, Qirong, Huang, Huiqiang, Lin, Tongyu, Jiang, Wenqi, Xia, Zhongjun, Duan, Huaxin, Rao, Huilan, Yao, Mengfei, Hu, Liyang
Published in PloS one (06.10.2016)
Published in PloS one (06.10.2016)
Get full text
Journal Article
Research Progress of Chimeric Antigen Receptor NK Cells in Treatment of Lymphoma
Hu, Run, Yao, Pei, Li, Junen, Gui, Renjie, Duan, Huaxin
Published in Zhongliu fangzhi yanjiu (01.12.2023)
Published in Zhongliu fangzhi yanjiu (01.12.2023)
Get full text
Journal Article
WDR4 as a potential indicator of clinical prognosis and immunotherapy in hepatocellular carcinoma
Lin, Chi, Wang, Juan, Ouyang, Long, Duan, Huaxin, Fan, Shasha
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase Ib/IIa trial to evaluate the safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced NSCLC
Wu, Chunjiao, Lv, Dongqing, Cui, Jiuwei, Wang, Zhen, Zhao, Hui, Duan, Huaxin, Duan, Ping, Yin, Yongmei, Pan, Yueyin, Liu, Fu-Nan, Kong, Chuize, Zhang, Jian, Li, Yongsheng, Han, Xinpeng, Liu, Baogang, He, Lijie, Qin, Zhiquan, Wu, Tao, Ji, Mei, Cheng, Ying
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize SIRT1 mRNA
Peng, Wei, Jiang, Junjie, Fu, Jia, Duan, Huaxin, Wang, Jia, Duan, Chaojun
Published in Epigenomics (01.04.2023)
Published in Epigenomics (01.04.2023)
Get full text
Journal Article
Phase Ib/IIa safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced solid tumors
Guo, Ye, Guo, Jun, Cheng, Ying, Wang, Zhen, Li, Yongsheng, Lv, Dongqing, Yin, Yongmei, Li, Guiling, Wu, Lingying, Huang, Yi, Wei, Shuqing, Shen, Lin, Duan, Huaxin, Cui, Jiuwei, Luo, Hong, Li, Xiumin, Nan, Kejun, Wang, Chunyan, Luo, Su-xia, Liu, Ruonan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial
Pu, Xingxiang, Xiao, Zemin, Li, Jia, Wu, Zhijun, Ma, Zhongxia, Weng, Jie, Xiao, Maoliang, Chen, Yanhua, Cao, Yongqing, Cao, Peiguo, Wang, Qianzhi, Xu, Yan, Li, Kang, Chen, Bolin, Xu, Fang, Liu, Liyu, Kong, Yi, Zhang, Hui, Duan, Huaxin, Wu, Lin
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2024)
Get full text
Journal Article
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer
Chen, Bolin, Yao, Wenxiu, Li, Xingya, Lin, Gen, Chu, Qian, Liu, Hailong, Du, Yingying, Lin, Jie, Duan, Huaxin, Wang, Huijuan, Xiao, Zemin, Sun, Hong, Liu, Liyu, Xu, Li, Xu, Yan, Xu, Fang, Kong, Yi, Pu, Xingxiang, Li, Kang, Wang, Qianzhi, Li, Jia, Li, Baiyong, Xia, Yu, Wu, Lin
Published in British journal of cancer (24.02.2024)
Published in British journal of cancer (24.02.2024)
Get full text
Journal Article
Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma
Hao, Jingcheng, Deng, Haimin, Yang, Yuan, Chen, Lidan, Wu, Qiang, Yao, Pei, Li, Junen, Li, Bowen, Jin, Xueli, Wang, Haiqing, Duan, Huaxin
Published in Oncology reports (01.11.2021)
Published in Oncology reports (01.11.2021)
Get full text
Journal Article
Effective targeted therapy based on dynamic monitoring of gene mutations in non-small cell lung cancer
Deng, Tan, Tang, Jiao, Zhou, Lijun, Duan, Huaxin
Published in Translational lung cancer research (01.08.2019)
Published in Translational lung cancer research (01.08.2019)
Get full text
Journal Article
Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer
Dai, Youyi, Duan, Huaxin, Duan, Chaojun, Zhou, Rongrong, He, Yuxiang, Tu, Qingsong, Shen, Liangfang
Published in Biochemical and biophysical research communications (15.01.2016)
Published in Biochemical and biophysical research communications (15.01.2016)
Get full text
Journal Article
Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study
Moore, Kathleen N., Sabanathan, Dhanusha, Du, Yiqun, Duan, Huaxin, Li, Xiumin, Wang, Feng, Marathe, Omkar, Yang, Hua, Makker, Vicky, Growdon, Whitfield, Coward, Jim, Zhao, Peng, Liu, Liming, Shi, Rong, Liu, Shengxue, Gu, Wei, Qiu, Yang, Zhu, Zhongyuan, Zhang, Jian, Hamilton, Erika P.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
MAEL contributes to gastric cancer progression by promoting ILKAP degradation
Zhang, Xing, Ning, Yichong, Xiao, Yuzhong, Duan, Huaxin, Qu, Guifang, Liu, Xin, Du, Yan, Jiang, Dejian, Zhou, Jianlin
Published in Oncotarget (26.12.2017)
Published in Oncotarget (26.12.2017)
Get full text
Journal Article
A multicenter, randomized, phase II trial of anlotinib plus docetaxel versus docetaxel in EGFR-negative NSCLC patients after progression on first-line platinum-base chemotherapy: ALTER-L018
Wu, Lin, Wu, Zhijun, Xiao, Zemin, Ma, Zhongsha, Weng, Jie, Chen, Yanhua, Cao, Yongqing, Cao, Peiguo, Xiao, Maoliang, Zhang, Hui, Duan, Huaxin, Wang, Qianzhi, Li, Jia, Xu, Yan, Pu, Xingxiang, Li, Kang
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A randomized phase II multi-institutional trial of anlotinib plus docetaxel versus docetaxel in EGFR-wild-type non-small cell lung cancer (NSCLC) patients after progression on first-line platinum-base chemotherapy: ALTER-L018
Wu, Lin, Wu, Zhijun, Xiao, Zemin, Weng, Jie, Ma, Zhongsha, Chen, Yanhua, Xiao, Maoliang, Cao, Yongqing, Duan, Huaxin, Cao, Peiguo, Zhang, Hui, Wang, Qianzhi, Li, Jia, Xu, Yan, Pu, Xingxiang, Li, Kang
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article